Previous 10 | Next 10 |
home / stock / orxoy / orxoy news
NEW YORK , June 15, 2020 /PRNewswire/ -- Virtual Investor Conferences today announced the agenda for the upcoming Global Virtual lnvestor Conference, the leading proprietary investor conference series. Individual investors, institutional investors, advisors and analysts are invited ...
UPPSALA, Sweden , May 19, 2020 /PRNewswire/ -- Today on 19 May 2020 , Orexo AB (publ) held an extraordinary general meeting. The extraordinary general meeting passed the following resolutions. Long-term incentive program LTIP 2020 The extraordinary general meeting resolved, in acco...
UPPSALA, Sweden and NEW YORK , May 18, 2020 /PRNewswire/ -- Orexo, a Swedih pharmaceutical company focused on improved pharmaceuticals and digital therapies, announced that it will partner with Lyfebulb, a patient empowerment platform, to work with substance abuse patients to id...
UPPSALA, Sweden , May 15, 2020 /PRNewswire/ -- Orexo's partner, Gesynta Pharma, today announces positive phase I results for OX-MPI (GS-248). Gesynta Pharma, who owns all the rights to OX-MPI (GS-248), aims to develop a treatment for the microvascular diseases in chronic inflammato...
Orexo AB ( OTCQX:ORXOY ) has secured exclusive U.S. rights to GAIA AG's ( GAIA -5.5% ) deprexis digital therapy to help patients to manage their symptoms of depression. More news on: Orexo AB (publ), Gaia, Inc., OREXO AB ORD, Healthcare stocks news, Read more ...
UPPSALA, Sweden , May 11, 2020 /PRNewswire/ -- Orexo AB (publ.) today announces it has acquired the exclusive US rights to GAIA AG's (GAIA) deprexis®, a digital therapy to help patients manage their symptoms of depression and one of the most researched digital therapies in the...
UPPSALA, Sweden , April 28, 2020 /PRNewswire/ -- Q1 2020 highlights Total net revenues of SEK 175.0 m (174.3), up 0.4 percent EBITDA of SEK 39.1 m (...
UPPSALA, Sweden , April 16, 2020 /PRNewswire/ -- Orexo AB (publ.) today announces the appointment of James Noble as Chairman of the Board. The resolution was taken today at the annual general meeting, in accordance with the nomination committee's proposal. Alongside James, Char...
UPPSALA, Sweden , April 16, 2020 /PRNewswire/ -- The shareholders in Orexo AB (publ), reg. no. 556500-0600, registered office Uppsala, are summoned to the extraordinary general meeting, to be held on Tuesday 19 May 2020 , at 11.00 am in Orexo's facilities at Rapsgatan 7E in Uppsala...
UPPSALA, Sweden , April 16, 2020 /PRNewswire/ -- Election of the board of directors and auditor The annual general meeting in Orexo AB (publ) on 16 April 2020 resolved, in accordance with the nomination committee's proposal, that the number of board members shall be eight with no de...
News, Short Squeeze, Breakout and More Instantly...
Orexo Q2 2024 Interim Report PR Newswire UPPSALA, Sweden , July 17, 2024 /PRNewswire/ -- Making progress, while the OX124 review time extended Q2 2024 highlights Total net revenues of SEK 154.0 m (157.7) EBITDA of SEK 5.0 m (5.6)...
Orexo shares new information on OX124, a high-dose naloxone rescue medication in development for opioid overdose PR Newswire UPPSALA, Sweden , July 16, 2024 /PRNewswire/ -- Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), today announces that the company has received...
Orexo AB´s sustainability work ranked among top 5% by EcoVadis PR Newswire UPPSALA, Sweden , July 10, 2024 /PRNewswire/ -- Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) announces that it has received a Gold Sustainability Rating by EcoVadis, one of the...